Patents by Inventor Christopher L. Parks

Christopher L. Parks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Camera and visitor user interfaces
    Patent number: 11937021
    Abstract: The present disclosure generally relates to camera and visitor user interfaces. In some examples, the present disclosure relates to techniques for switching between configurations of a camera view. In some examples, the present disclosure relates to displaying indications of visitors detected by an accessory device of the home automation system. In some examples, the present disclosure relates to displaying a multi-view camera user interface.
    Type: Grant
    Filed: February 17, 2023
    Date of Patent: March 19, 2024
    Assignee: Apple Inc.
    Inventors: Dennis S. Park, Patrick L. Coffman, Christopher John Sanders
  • Air handling unit
    Patent number: 11927364
    Abstract: An air handling unit (AHU) for a heating, ventilation, air conditioning, and refrigeration (HVACR) system includes a housing and a combustion heater disposed within the housing. The housing includes a combustion section with a first channel and a second channel. The combustion heater includes heat exchanger tubes and a tube support that supports heat exchanger tubes within the combustion section. The tube support slidably disposed in the first channel and the second channel. The combustion heater configured to be slidably removable from the AHU. An AHU for an HVACR system includes a housing with a fan section and a fan assembly disposed within the housing. The fan assembly including a pair of grooves slidably disposed on a pair of rails of the housing. The fan assembly configured to be both slidably removable from the AHU and liftably removable from the AHU.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: March 12, 2024
    Assignee: TRANE INTERNATIONAL INC.
    Inventors: Christopher Daniel, Jason William Parks, Gregory L. Meeuwsen, Nathan Wagers, Chasity Webb, Anthony Chiles, Gregory Edmund Beltran, Aaron Allison Stevens, Stephen Kowalski, Jason Harpst
  • Recombinant viral vectors
    Patent number: 11891416
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: February 6, 2024
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE, INC.
    Inventors: Christopher L. Parks, Ivo Lorenz, Sanjay K. Phogat, Timothy J. Zamb
  • NOVEL VESICULAR STOMATITIS VIRUS AND VIRUS RESCUE SYSTEM
    Publication number: 20230340535
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: May 16, 2023
    Publication date: October 26, 2023
    Inventors: Christopher L. PARKS, Maoli YUAN, Kevin WRIGHT, Christy JURGENS
  • Vesicular stomatitis virus and virus rescue system
    Patent number: 11667930
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: June 6, 2023
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE, INC.
    Inventors: Christopher L. Parks, Maoli Yuan, Kevin Wright, Christy Jurgens
  • RECOMBINANT VIRAL VECTORS
    Publication number: 20210040158
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: October 19, 2020
    Publication date: February 11, 2021
    Inventors: Christopher L. Parks, Ivo Lorenz, Sanjay K. Phogat, Timothy J. Zamb
  • Transgenic VERO-CD4/CCR5 cell line
    Patent number: 10894080
    Abstract: The present relation relates to a transgenic Vero cell line expressing CD4 and CCR5. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: January 19, 2021
    Inventors: Christopher L. Parks, Wayne C. Koff
  • Recombinant viral vectors
    Patent number: 10844095
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: November 24, 2020
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Ivo Lorenz, Sanjay K. Phogat, Timothy J. Zamb
  • Optimized HIV envelope gene and expression thereof
    Patent number: 10792357
    Abstract: The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: October 6, 2020
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Maoli Yuan, Xinsheng Zhang, Aaron Wilson, Angela Grazia Lombardo, Eddy Sayeed, Josephine Helena Cox, Takashi Hironaka, Makoto Inoue, Hiroto Hara
  • NOVEL VESICULAR STOMATITIS VIRUS AND VIRUS RESCUE SYSTEM
    Publication number: 20200172932
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: December 17, 2019
    Publication date: June 4, 2020
    Inventors: Christopher L. Parks, Maoli Yuan, Kevin Wright, Christy Jurgens
  • Vesicular stomatitis virus and virus rescue system
    Patent number: 10544430
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines as well as the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: January 28, 2020
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Maoli Yuan, Kevin Wright, Christy Jurgens
  • TRANSGENIC VERO-CD4/CCR5 CELL LINE
    Publication number: 20190216915
    Abstract: The present relation relates to a transgenic Vero cell line expressing CD4 and CCR5. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: February 15, 2019
    Publication date: July 18, 2019
    Inventors: Christopher L. Parks, Wayne C. Koff
  • OPTIMIZED HIV ENVELOPE GENE AND EXPRESSION THEREOF
    Publication number: 20190201522
    Abstract: The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.
    Type: Application
    Filed: March 4, 2019
    Publication date: July 4, 2019
    Inventors: Christopher L. Parks, Maoli Yuan, Xinsheng Zhang, Aaron Wilson, Angela Grazia Lombardo, Eddy Sayeed, Josephine Helena Cox, Takashi Hironaka, Makoto Inoue, Hiroto Hara
  • RECOMBINANT VIRAL VECTORS
    Publication number: 20190153043
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: February 4, 2019
    Publication date: May 23, 2019
    Inventors: Christopher L. Parks, Ivo Lorenz, Sanjay K. Phogat, Timothy J. Zamb
  • Transgenic Vero-CD4/CCR5 cell line
    Patent number: 10279027
    Abstract: The present relation relates to a transgenic Vero cell line expressing CD4 and CCR5. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: May 7, 2019
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Wayne C. Koff
  • Optimized HIV envelope gene and expression thereof
    Patent number: 10220087
    Abstract: The present invention relates to a vector(s) containing and expressing an optimized HIV EnvF gene, methods for making the same and cell substrates qualified for vaccine production which may comprise vector(s) containing optimized HIV genes.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: March 5, 2019
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Maoli Yuan, Xinsheng Zhang, Aaron Wilson, Angela Grazia Lombardo, Eddy Sayeed, Josephine Helena Cox, Takashi Hironaka, Makoto Inoue, Hiroto Hara
  • Recombinant viral vectors
    Patent number: 10202424
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: February 12, 2019
    Assignee: International AIDS Vaccine Initiative
    Inventors: Christopher L. Parks, Ivo Lorenz, Sanjay K. Phogat, Timothy J. Zamb
  • Methods to improve vector expression and genetic stability
    Patent number: 9944935
    Abstract: The present invention relates to methods of developing gene inserts that are more compatible with the host vectors by modifying a protein sequence to lessen potential interference with vector propagation while ensuring that the protein is expressed and processed efficiently and maintains desired structural features, and designing a gene with a nucleotide sequence that resembles the base composition of the host vector genome.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: April 17, 2018
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Kevin J. Wright, Maoli Yuan, Christy K. Jurgens, Xinsheng Zhang, Arban Domi, Simon Hoffenberg, Maria J. Chiuchiolo, Svetlana Rabinovich, Aaron J. Wilson, Ivo C. Lorenz
  • Replication-competent VSV-HIV Env vaccines
    Patent number: 9925258
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: March 27, 2018
    Assignee: INTERNATIONAL AIDS VACCINE INITIATIVE
    Inventors: Christopher L. Parks, Wayne C. Koff
  • RECOMBINANT VIRAL VECTORS
    Publication number: 20170327544
    Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: July 31, 2017
    Publication date: November 16, 2017
    Inventors: Christopher L. PARKS, Ivo Lorenz, Sanjay K. Phogat, Timothy J. Zamb